Sun Pharmaceutical Industries Limited (BOM:524715)
India · Delayed Price · Currency is INR 1,837.15
+13.15 (0.72%)
At close: Jun 19, 2026
BOM:524715 Revenue
In the fiscal year ending March 31, 2026, Sun Pharmaceutical Industries had annual revenue of 584.62B INR with 11.19% growth. Sun Pharmaceutical Industries had revenue of 146.12B in the quarter ending March 31, 2026, with 12.76% growth.
Revenue
584.62B
Revenue Growth
+11.19%
P/S Ratio
7.65
Revenue / Employee
13.60M
Employees
43,000
Market Cap
4.47T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 584.62B | 58.84B | 11.19% |
| Mar 31, 2025 | 525.78B | 40.82B | 8.42% |
| Mar 31, 2024 | 484.97B | 46.11B | 10.51% |
| Mar 31, 2023 | 438.86B | 52.31B | 13.53% |
| Mar 31, 2022 | 386.54B | 51.56B | 15.39% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dr. Reddy's Laboratories | 335.93B |
| Lupin | 279.58B |
| Torrent Pharmaceuticals | 139.80B |
| Jubilant Pharmova | 82.80B |
| Abbott India | 69.29B |
| Granules India | 53.66B |
| J. B. Chemicals & Pharmaceuticals | 41.48B |
| GlaxoSmithKline Pharmaceuticals | 38.22B |
Sun Pharmaceutical Industries News
- 2 days ago - Sun Pharma to acquire Innovcare Lifesciences for $28.7 million - Reuters
- 2 days ago - Sun Pharmaceutical to acquire Innovcare Lifesciences for Rs 271.2 crore - Business Upturn
- 5 days ago - Brokerage calls today, June 17: Sun Pharma, Polycab, AU SFB, Navin Fluorine, Coforge, PB Fintech in focus - Business Upturn
- 5 days ago - Macquarie reiterates ‘Outperform’ on Sun Pharma, maintains target price of Rs 2,150 - Business Upturn
- 8 days ago - Sun Pharmaceutical Industries reports arrest of independent director Gautam Doshi - Business Upturn
- 11 days ago - Sun Pharmaceutical sets Rs 5 per share final dividend with July 7 record date - Business Upturn
- 14 days ago - Nifty 50 top gainers in morning trades today, June 8: Apollo Hospitals up 1.0%, SBI gains 0.8%, Sun Pharma rises 0.6% - Business Upturn
- 26 days ago - Sun Pharma share price target: Brokerages remain positive on specialty growth and strong India business - Business Upturn